Novel Liquid Biomarker Panels for A Very Early Response Capturing of NSCLC Therapies in Advanced Stages

Computed tomography (CT) scans are the gold standard to measure treatment success of non-small cell lung cancer (NSCLC) therapies. Here, we investigated the very early tumor response of patients receiving chemotherapy or targeted therapies using a panel of already established and explorative liquid...

Descripción completa

Detalles Bibliográficos
Autores principales: Janke, Florian, Bozorgmehr, Farastuk, Wrenger, Sabine, Dietz, Steffen, Heussel, Claus P., Heussel, Gudula, Silva, Carlos F., Rheinheimer, Stephan, Feisst, Manuel, Thomas, Michael, Golpon, Heiko, Günther, Andreas, Sültmann, Holger, Muley, Thomas, Janciauskiene, Sabina, Meister, Michael, Schneider, Marc A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7226444/
https://www.ncbi.nlm.nih.gov/pubmed/32290637
http://dx.doi.org/10.3390/cancers12040954

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7226444/
https://www.ncbi.nlm.nih.gov/pubmed/32290637
http://dx.doi.org/10.3390/cancers12040954

Ejemplares similares